8/18/2022 9:39:05 PM
Accelerate Diagnostics Prices Public Offering Of 17.50 Mln Shares $2.00/shr
8/15/2022 8:20:01 AM
Accelerate Diagnostics Q2 Net Loss/shr Narrows To $0.23 From $0.36 Prior Year; Stock Up
8/15/2022 6:55:10 AM
BD To Sell Accelerate Pheno System And Accelerate Arc Module Test Kits Via Global Sales Network In Territories
7/11/2022 8:10:19 AM
Accelerate Diagnostics Announces Commercialization Of Accelerate Arc System In Europe
5/16/2022 8:08:26 AM
Accelerate Diagnostics Announces Commercialization Of Accelerate Arc System Having Completed IVD Registration With FDA
3/28/2022 8:12:35 AM
Accelerate Diagnostics Reports Launch Of Accelerate Arc™ Module And BC Kit
3/9/2022 10:27:45 AM
William Blair Reiterates Accelerate Diagnostics, Inc (AXDX) At Outperform
1/13/2022 9:16:56 AM
Accelerate Diagnostics Expects Q4 Total Revenue To Be About $3.3 Mln Vs. $3.1 Mln Prior Year
11/22/2021 7:26:16 AM
Accelerate Publishes Improving Outcomes &Antibiotic Stewardship Study In Journal Clinical Infectious Diseases
8/3/2021 8:12:02 AM
Accelerate Diagnostics Gets CE Mark For Fast Antimicrobial Susceptibility Test For Use With Existing ID Systems